97.24  2.03 (2.13%)		09-30 16:00
Open: 95.52 High: 98.4095 Volume: 1,483,913		Pre. Close: 95.21 Low: 94.5 Market Cap: 7,524(M)

Short term
Mid term
Targets	6-month :	114.94	1-year :	134.25
Resists	First :	98.4	Second :	114.94
Pivot price	93.38
Supports	First :	90.58	Second :	85.75
MAs	MA(5) :	94.48	MA(20) :	92.98
	MA(100) :	78.54	MA(250) :	58.17
MACD	MACD :	1.8	Signal :	1.8
%K %D	K(14,3) :	75.4	D(3) :	72.8
RSI	RSI(14): 60.5
52-week	High :	98.4	Low :	30.07

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ HNGE ] has closed below upper band by 9.5%. Bollinger Bands are 39% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	98.54 - 98.94	98.94 - 99.31
Low:	93.53 - 93.96	93.96 - 94.37
Close:	96.54 - 97.23	97.23 - 97.88

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Wed, 30 Sep 2026
A 10% stockholder proposes selling Hinge Health (HNGE) shares after six prior sales. - Stock Titan

Wed, 30 Sep 2026
After selling 49,064 shares, a 10% holder proposes another Hinge Health (HNGE) share sale. - Stock Titan

Wed, 30 Sep 2026
After six sales, a 10% holder proposes another share sale at Hinge Health (HNGE). - Stock Titan

Wed, 30 Sep 2026
A 10% stockholder plans a Hinge Health (HNGE) share sale through Raymond James. - Stock Titan

Wed, 30 Sep 2026
Needham & Company LLC Issues Positive Forecast for Hinge Health (NYSE:HNGE) Stock Price - marketbeat.com

Tue, 29 Sep 2026
Hinge Health Growth Outlook Supported by Member Gains, New Products, BofA Says - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	62 (M)
Shares Float	50 (M)
Held by Insiders	4.8 (%)
Held by Institutions	95.3 (%)
Shares Short	4,830 (K)
Shares Short P.Month	5,630 (K)

EPS	8.22
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.28
Profit Margin	15.1 %
Operating Margin	19 %
Return on Assets (ttm)	7.6 %
Return on Equity (ttm)	30.3 %
Qtrly Rev. Growth	53 %
Gross Profit (p.s.)	9.74
Sales Per Share	11.52
EBITDA (p.s.)	1.53
Qtrly Earnings Growth	0 %
Operating Cash Flow	291 (M)
Levered Free Cash Flow	300 (M)

PE Ratio	11.82
PEG Ratio	0
Price to Book value	22.66
Price to Sales	8.43
Price to Cash Flow	20.88

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.